2016 Global Drug Supply, Safety and Traceability Report: Using 2015 Lot-Level Learnings to Understand Future Serialization Challenges
Lot-level requirements for the U.S. Drug Supply Chain Security Act (DSCSA) took effect in 2015. How did the industry adapt to the regulations, and what does the lot-level experience tell us about the supply chain’s readiness for serialization?
The 2016 Global Drug Supply, Safety and Traceability Report draws on a survey of 331 supply chain professionals and data from the TraceLink Life Sciences Cloud to detail the 2015 compliance experience, and the outlook for the November 2017 serialization deadline.
Get the report now to learn:
- The true shape of today’s supply chain.
- The impact of lot-level compliance on staffing, exceptions, business systems, and more.
- How trade partner demands complicated the challenge.
- The risks the industry faces as it moves to a fully electronic world.